{"version":"company-facts.v1","source":"https://secwatch.observer","generated_at":"2026-07-13T12:11:11.912595+00:00","company":{"ticker":"THC","cik":70318,"company_name":"TENET HEALTHCARE CORP"},"pagination":{"limit":100,"returned":38,"next_cursor":null},"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer","counterparties":{"contract_counterparty":[{"display_name":"Barclays Bank PLC","detail":"credit_facility","count":1,"first_seen":"2023-09-08T23:59:59+00:00","last_seen":"2023-09-08T23:59:59+00:00","evidence_fact_ids":[114702]}],"lender":[{"display_name":"The Bank of New York Mellon Trust Company, N.A.","detail":"senior_notes","count":3,"first_seen":"2023-05-16T23:59:59+00:00","last_seen":"2025-11-18T23:59:59+00:00","evidence_fact_ids":[37881,37882,151750]},{"display_name":"Barclays Bank PLC","detail":"credit_facility","count":1,"first_seen":"2025-11-05T23:59:59+00:00","last_seen":"2025-11-05T23:59:59+00:00","evidence_fact_ids":[38542]},{"display_name":"JPMorgan Chase Bank, N.A.","detail":"revolving_credit","count":1,"first_seen":"2025-11-05T23:59:59+00:00","last_seen":"2025-11-05T23:59:59+00:00","evidence_fact_ids":[38541]}]},"facts":[{"fact_type":"shareholder_vote","fact_key":"a06ca3a5c376cded1bafded2a7d6628fbcef2602","cik":70318,"ticker":"THC","company_name":"TENET HEALTHCARE CORP","filed_at":"2026-05-29T20:05:19+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2026-05-27","outcome":"passed","proposal_text":"Ratification of the selection of Deloitte & Touche LLP as independent registered public accountants","proposal_type":"auditor_ratification","results":[{"broker_non_votes":"—","subject":null,"votes_abstain":"29,318","votes_against":"470,477","votes_for":"79,422,386","votes_withheld":null}]},"claim":"TENET HEALTHCARE CORP shareholders approved Ratification of the selection of Deloitte & Touche LLP as independent registered public accountants at the 2026-05-27 meeting.","evidence_excerpt":"3. The Company’s shareholders approved the ratification of the selection of Deloitte & Touche LLP as the Company’s independent registered public accountants for the year ending December 31, 2026: FOR AGAINST ABSTAIN BROKER NON-VOTES 79,422,386 470,477 29,318 —","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000070318-26-000028","anchor_url":"https://secwatch.observer/filing/0000070318-26-000028#claim-a06ca3a5c376cded1bafded2a7d6628fbcef2602","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/70318/000007031826000028/0000070318-26-000028-index.htm"},{"fact_type":"shareholder_vote","fact_key":"e0686b627f23ab84b5cdbff00d8eb4e42e2db21d","cik":70318,"ticker":"THC","company_name":"TENET HEALTHCARE CORP","filed_at":"2026-05-29T20:05:19+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2026-05-27","outcome":"passed","proposal_text":"Advisory vote on executive compensation","proposal_type":"say_on_pay","results":[{"broker_non_votes":"5,510,667","subject":null,"votes_abstain":"39,895","votes_against":"11,817,273","votes_for":"62,554,346","votes_withheld":null}]},"claim":"TENET HEALTHCARE CORP shareholders approved Advisory vote on executive compensation at the 2026-05-27 meeting.","evidence_excerpt":"2.    The Company’s shareholders approved, on an advisory basis, the Company’s executive compensation: FOR AGAINST ABSTAIN BROKER NON-VOTES 62,554,346 11,817,273 39,895 5,510,667","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000070318-26-000028","anchor_url":"https://secwatch.observer/filing/0000070318-26-000028#claim-e0686b627f23ab84b5cdbff00d8eb4e42e2db21d","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/70318/000007031826000028/0000070318-26-000028-index.htm"},{"fact_type":"shareholder_vote","fact_key":"445ca370b86ce6ee08fc637421126b41dc2d468c","cik":70318,"ticker":"THC","company_name":"TENET HEALTHCARE CORP","filed_at":"2026-05-29T20:05:19+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2026-05-27","outcome":"passed","proposal_text":"Election of Directors","proposal_type":"director_election","results":[{"broker_non_votes":"5,510,667","subject":"Saumya Sutaria","votes_abstain":"76,905","votes_against":"2,036,933","votes_for":"72,297,676","votes_withheld":null},{"broker_non_votes":"5,510,667","subject":"J. Robert Kerrey","votes_abstain":"34,334","votes_against":"2,539,818","votes_for":"71,837,362","votes_withheld":null},{"broker_non_votes":"5,510,667","subject":"Vineeta Agarwala","votes_abstain":"26,934","votes_against":"621,321","votes_for":"73,763,259","votes_withheld":null},{"broker_non_votes":"5,510,667","subject":"James L. Bierman","votes_abstain":"67,742","votes_against":"550,313","votes_for":"73,793,459","votes_withheld":null},{"broker_non_votes":"5,510,667","subject":"Roy Blunt","votes_abstain":"70,555","votes_against":"572,299","votes_for":"73,768,660","votes_withheld":null},{"broker_non_votes":"5,510,667","subject":"Richard W. Fisher","votes_abstain":"68,141","votes_against":"583,669","votes_for":"73,759,704","votes_withheld":null},{"broker_non_votes":"5,510,667","subject":"Meghan M. FitzGerald","votes_abstain":"27,048","votes_against":"1,222,005","votes_for":"73,162,461","votes_withheld":null},{"broker_non_votes":"5,510,667","subject":"Cecil D. Haney","votes_abstain":"79,850","votes_against":"549,561","votes_for":"73,782,103","votes_withheld":null},{"broker_non_votes":"5,510,667","subject":"Christopher S. Lynch","votes_abstain":"69,479","votes_against":"570,200","votes_for":"73,771,835","votes_withheld":null},{"broker_non_votes":"5,510,667","subject":"Richard J. Mark","votes_abstain":"68,657","votes_against":"574,980","votes_for":"73,767,877","votes_withheld":null},{"broker_non_votes":"5,510,667","subject":"Tammy Romo","votes_abstain":"29,021","votes_against":"1,233,024","votes_for":"73,149,469","votes_withheld":null},{"broker_non_votes":"5,510,667","subject":"Nadja Y. West","votes_abstain":"41,884","votes_against":"710,537","votes_for":"73,659,093","votes_withheld":null}]},"claim":"TENET HEALTHCARE CORP shareholders approved Election of Directors at the 2026-05-27 meeting.","evidence_excerpt":"1.    The Company’s shareholders elected the following directors to serve on the Company’s Board of Directors, each to serve until the next annual meeting of shareholders or until his or her successor is duly elected or qualified, whichever is later, or until the director’s earlier resignation or removal: FOR AGAINST ABSTAIN BROKER NON-VOTES Saumya Sutaria 72,297,676 2,036,933 76,905 5,510,667 J. Robert Kerrey 71,837,362 2,539,818 34,334 5,510,667 Vineeta Agarwala 73,763,259 621,321 26,934 5,510,667 James L. Bierman 73,793,459 550,313 67,742 5,510,667 Roy Blunt 73,768,660 572,299 70,555 5,510,667 Richard W. Fisher 73,759,704 583,669 68,141 5,510,667 Meghan M. FitzGerald 73,162,461 1,222,005 27,048 5,510,667 Cecil D. Haney 73,782,103 549,561 79,850 5,510,667 Christopher S. Lynch 73,771,835 570,200 69,479 5,510,667 Richard J. Mark 73,767,877 574,980 68,657 5,510,667 Tammy Romo 73,149,469 1,233,024 29,021 5,510,667 Nadja Y. West 73,659,093 710,537 41,884 5,510,667","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000070318-26-000028","anchor_url":"https://secwatch.observer/filing/0000070318-26-000028#claim-445ca370b86ce6ee08fc637421126b41dc2d468c","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/70318/000007031826000028/0000070318-26-000028-index.htm"},{"fact_type":"earnings_release","fact_key":"3b635174e54056fdb898480ddb3d52f7980d0a42","cik":70318,"ticker":"THC","company_name":"TENET HEALTHCARE CORP","filed_at":"2026-04-30T23:59:59+00:00","payload":{"eps_text":"$8.01 per diluted share","guidance_signal":"reaffirmed","item_codes_triggered":["2.02"],"net_income_text":"$702 million","period_text":"the quarter ended March 31, 2026","report_date":"2026-04-30","result_type":"reported_results","revenue_text":null},"claim":"TENET HEALTHCARE CORP reported the quarter ended March 31, 2026 results: net income $702 million, EPS $8.01 per diluted share. Guidance reaffirmed.","evidence_excerpt":"herein by reference. \n\n--- EX-99.1 (EX-99.1) ---\n\nTenet Reports Strong First Quarter 2026 Results • Net income available to common shareholders in first quarter 2026 was $702 million, or $8.01 per diluted share • Adjusted diluted earnings per share 1 increased 10.6% to $4.82 in first quarter 2026 compared to $4.36 in first quarter 2025 • Consolidated Adjusted","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000070318-26-000023","anchor_url":"https://secwatch.observer/filing/0000070318-26-000023#claim-3b635174e54056fdb898480ddb3d52f7980d0a42","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/70318/000007031826000023/0000070318-26-000023-index.htm"},{"fact_type":"debt_financing","fact_key":"2bb0bdf715f6fd5489c00fa2c010a0935cd84c18","cik":70318,"ticker":"THC","company_name":"TENET HEALTHCARE CORP","filed_at":"2025-11-18T23:59:59+00:00","payload":{"counterparty":"The Bank of New York Mellon Trust Company, N.A.","effective_date":"2025-11-18","event":"incurrence","instrument_type":"senior_notes","interest_rate_text":"6.000%","item_codes_triggered":["2.03"],"maturity_text":"2033","principal_text":"$750,000,000"},"claim":"TENET HEALTHCARE CORP incurred senior notes of $750,000,000 with The Bank of New York Mellon Trust Company, N.A. at 6.000% maturing 2033.","evidence_excerpt":"and $750,000,000 in aggregate principal amount of 6.000% senior notes due 2033 (the “Senior Notes” and together with the First Lien Notes, the “Notes”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-25-286146","anchor_url":"https://secwatch.observer/filing/0001193125-25-286146#claim-2bb0bdf715f6fd5489c00fa2c010a0935cd84c18","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/70318/000119312525286146/0001193125-25-286146-index.htm"},{"fact_type":"debt_financing","fact_key":"92f1c7adf905c6dda89dd875c43086212d794ad4","cik":70318,"ticker":"THC","company_name":"TENET HEALTHCARE CORP","filed_at":"2025-11-18T23:59:59+00:00","payload":{"counterparty":"The Bank of New York Mellon Trust Company, N.A.","effective_date":"2025-11-18","event":"incurrence","instrument_type":"senior_notes","interest_rate_text":"5.500%","item_codes_triggered":["2.03"],"maturity_text":"2032","principal_text":"$1,500,000,000"},"claim":"TENET HEALTHCARE CORP incurred senior notes of $1,500,000,000 with The Bank of New York Mellon Trust Company, N.A. at 5.500% maturing 2032.","evidence_excerpt":"On November 18, 2025, Tenet Healthcare Corporation (“Tenet”) issued $1,500,000,000 in aggregate principal amount of 5.500% senior secured first lien notes due 2032 (the “First Lien Notes”)","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-25-286146","anchor_url":"https://secwatch.observer/filing/0001193125-25-286146#claim-92f1c7adf905c6dda89dd875c43086212d794ad4","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/70318/000119312525286146/0001193125-25-286146-index.htm"},{"fact_type":"debt_financing","fact_key":"4797c90c077122fd006b9876bf308fe64d9ba164","cik":70318,"ticker":"THC","company_name":"TENET HEALTHCARE CORP","filed_at":"2025-11-05T23:59:59+00:00","payload":{"counterparty":"Barclays Bank PLC, as administrative agent","effective_date":"2025-11-04","event":"amendment","instrument_type":"credit_facility","interest_rate_text":"base rate plus a margin equal to 0.25% per annum","item_codes_triggered":["2.03"],"maturity_text":"November 4, 2030","principal_text":"up to $200 million"},"claim":"TENET HEALTHCARE CORP amended credit facility of up to $200 million with Barclays Bank PLC, as administrative agent at base rate plus a margin equal to 0.25% per annum maturing November 4, 2030.","evidence_excerpt":"has an effective date of November 4, 2025 and provides for, subject to borrowing availability, revolving loans in an aggregate principal amount of up to $1.9 billion with a $200 million sub-facility for letters of credit. Tenet’s borrowing availability under the ABL Agreement is calculated by reference to a borrowing base which is determined by specified","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-25-266885","anchor_url":"https://secwatch.observer/filing/0001193125-25-266885#claim-4797c90c077122fd006b9876bf308fe64d9ba164","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/70318/000119312525266885/0001193125-25-266885-index.htm"},{"fact_type":"debt_financing","fact_key":"466d7e636f3c93c6adbaa108d457a10608491d84","cik":70318,"ticker":"THC","company_name":"TENET HEALTHCARE CORP","filed_at":"2025-11-05T23:59:59+00:00","payload":{"counterparty":"JPMorgan Chase Bank, N.A., as administrative agent","effective_date":"2025-11-04","event":"incurrence","instrument_type":"revolving_credit","interest_rate_text":"Term SOFR, Daily Simply SOFR or EURIBOR Rate plus an applicable margin ranging f","item_codes_triggered":["2.03"],"maturity_text":"November 4, 2030","principal_text":"up to $1.9 billion"},"claim":"TENET HEALTHCARE CORP incurred revolving credit of up to $1.9 billion with JPMorgan Chase Bank, N.A., as administrative agent at Term SOFR, Daily Simply SOFR or EURIBOR Rate plus an applicable margin ranging f maturing November 4, 2030.","evidence_excerpt":"The ABL Agreement has an effective date of November 4, 2025 and provides for, subject to borrowing availability, revolving loans in an aggregate principal amount of up to $1.9 billion with a $200 million sub-facility for letters of credit. Tenet’s borrowing availability under the ABL Agreement is calculated by reference to a borrowing base which is determined","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-25-266885","anchor_url":"https://secwatch.observer/filing/0001193125-25-266885#claim-466d7e636f3c93c6adbaa108d457a10608491d84","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/70318/000119312525266885/0001193125-25-266885-index.htm"},{"fact_type":"executive_change","fact_key":"286d5fa923","cik":70318,"ticker":"THC","company_name":"TENET HEALTHCARE CORP","filed_at":"2025-06-05T23:59:59+00:00","payload":{"action":"promoted","action_category":"role_change","departure_tone":"not_applicable","effective_date":"2025-05-30","interim":false,"role":"Chief Operating Officer","role_category":"coo","successor_name":null,"successor_named":false},"claim":"Lisa Y. Foo changed role as Chief Operating Officer at TENET HEALTHCARE CORP.","evidence_excerpt":"On May 30, 2025 , Lisa Y. Foo was promoted to Chief Operating Officer of Tenet Healthcare Corporation (the “Company”), a newly created position within the Company, effective immediately.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000070318-25-000023","anchor_url":"https://secwatch.observer/filing/0000070318-25-000023#claim-286d5fa923","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/70318/000007031825000023/0000070318-25-000023-index.htm"},{"fact_type":"earnings_release","fact_key":"33a31b278dfccc875be9a9283786d785923d0c2a","cik":70318,"ticker":"THC","company_name":"TENET HEALTHCARE CORP","filed_at":"2024-04-30T23:59:59+00:00","payload":{"eps_text":"$21.38","guidance_signal":"raised","item_codes_triggered":["2.02"],"net_income_text":"$2,151","period_text":"quarter ended March 31, 2024","report_date":"2024-04-30","result_type":"reported_results","revenue_text":"$5,368"},"claim":"TENET HEALTHCARE CORP reported quarter ended March 31, 2024 results: revenue $5,368, net income $2,151, EPS $21.38. Guidance raised.","evidence_excerpt":"results for first quarter 2024 versus first quarter 2023 are as follows: Three Months Ended March 31, ($ in millions, except per share results) 2024 2023 Net operating revenues $5,368 $5,021 Net income available to Tenet common shareholders from continuing operations $2,151 $143 Net income available to Tenet common shareholders from continuing operations per","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000070318-24-000030","anchor_url":"https://secwatch.observer/filing/0000070318-24-000030#claim-33a31b278dfccc875be9a9283786d785923d0c2a","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/70318/000007031824000030/0000070318-24-000030-index.htm"},{"fact_type":"earnings_release","fact_key":"e71b07ae5cb772ed5ca2d09456d186df44a6f6cc","cik":70318,"ticker":"THC","company_name":"TENET HEALTHCARE CORP","filed_at":"2024-02-08T23:59:59+00:00","payload":{"eps_text":"$5.71 per diluted share","guidance_signal":"raised","item_codes_triggered":["2.02"],"net_income_text":"$611 million","period_text":"the year ended December 31, 2023","report_date":"2024-02-08","result_type":"reported_results","revenue_text":"$20,548"},"claim":"TENET HEALTHCARE CORP reported the year ended December 31, 2023 results: revenue $20,548, net income $611 million, EPS $5.71 per diluted share. Guidance raised.","evidence_excerpt":"as follows: Three Months Ended December 31, Twelve Months Ended December 31, ($ in millions, except per share results) 2023 2022 2023 2022 Net operating revenues $5,379 $4,990 $20,548 $19,174 Net income available to Tenet common shareholders from continuing operations $244 $102 $611 $410 Net income available to Tenet common shareholders from continuing","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000070318-24-000011","anchor_url":"https://secwatch.observer/filing/0000070318-24-000011#claim-e71b07ae5cb772ed5ca2d09456d186df44a6f6cc","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/70318/000007031824000011/0000070318-24-000011-index.htm"},{"fact_type":"earnings_release","fact_key":"4b59783169ebb2f70e90b1d725f55335af766a19","cik":70318,"ticker":"THC","company_name":"TENET HEALTHCARE CORP","filed_at":"2024-02-08T23:59:59+00:00","payload":{"eps_text":"$2.30 per diluted share","guidance_signal":"raised","item_codes_triggered":["2.02"],"net_income_text":"$244 million","period_text":"the quarter ended December 31, 2023","report_date":"2024-02-08","result_type":"reported_results","revenue_text":"$5,379"},"claim":"TENET HEALTHCARE CORP reported the quarter ended December 31, 2023 results: revenue $5,379, net income $244 million, EPS $2.30 per diluted share. Guidance raised.","evidence_excerpt":"2022 are as follows: Three Months Ended December 31, Twelve Months Ended December 31, ($ in millions, except per share results) 2023 2022 2023 2022 Net operating revenues $5,379 $4,990 $20,548 $19,174 Net income available to Tenet common shareholders from continuing operations $244 $102 $611 $410 Net income available to Tenet common shareholders from","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000070318-24-000011","anchor_url":"https://secwatch.observer/filing/0000070318-24-000011#claim-4b59783169ebb2f70e90b1d725f55335af766a19","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/70318/000007031824000011/0000070318-24-000011-index.htm"},{"fact_type":"executive_change","fact_key":"3b3013d965","cik":70318,"ticker":"THC","company_name":"TENET HEALTHCARE CORP","filed_at":"2023-12-13T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2023-12-11","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Vineeta Agarwala was appointed as Director at TENET HEALTHCARE CORP.","evidence_excerpt":"On December 11, 2023 , the Board of Directors (the “Board”) of Tenet Healthcare Corporation (the “Company”) appointed Vineeta Agarwala to the Board, effective immediately.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000070318-23-000060","anchor_url":"https://secwatch.observer/filing/0000070318-23-000060#claim-3b3013d965","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/70318/000007031823000060/0000070318-23-000060-index.htm"},{"fact_type":"earnings_release","fact_key":"eac5e42dc72407431edbef8bdb41b695ccdd610f","cik":70318,"ticker":"THC","company_name":"TENET HEALTHCARE CORP","filed_at":"2023-10-30T23:59:59+00:00","payload":{"eps_text":"$0.94","guidance_signal":"raised","item_codes_triggered":["2.02"],"net_income_text":"$101 million","period_text":"quarter ended September 30, 2023","report_date":"2023-10-30","result_type":"reported_results","revenue_text":"$5,066"},"claim":"TENET HEALTHCARE CORP reported quarter ended September 30, 2023 results: revenue $5,066, net income $101 million, EPS $0.94. Guidance raised.","evidence_excerpt":"2022 are as follows: Three Months Ended September 30, Nine Months Ended September 30, ($ in millions, except per share results) 2023 2022 2023 2022 Net operating revenues $5,066 $4,801 $15,169 $14,184 Net income available to Tenet common shareholders from continuing operations $101 $131 $367 $308 Net income available to Tenet common shareholders from","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0000070318-23-000054","anchor_url":"https://secwatch.observer/filing/0000070318-23-000054#claim-eac5e42dc72407431edbef8bdb41b695ccdd610f","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/70318/000007031823000054/0000070318-23-000054-index.htm"},{"fact_type":"material_agreement","fact_key":"11c2c0efe699b4a4f26898531a4247bb3de38251","cik":70318,"ticker":"THC","company_name":"TENET HEALTHCARE CORP","filed_at":"2023-09-08T23:59:59+00:00","payload":{"action":"amendment","agreement_name":"LC Amendment","agreement_type":"credit_facility","counterparty":"Barclays Bank PLC","effective_date":"2023-09-07","item_codes_triggered":["1.01"],"value_text":"$200 million"},"claim":"TENET HEALTHCARE CORP amended LC Amendment with Barclays Bank PLC valued at $200 million (effective 2023-09-07).","evidence_excerpt":"On September 7, 2023 (the “Closing Date”), Tenet Healthcare Corporation, a Nevada corporation (“Tenet”), entered into an Amendment No. 6 (the “LC Amendment”) to extend its existing Letter of Credit Facility Agreement, dated as of March 7, 2014 (as amended by the LC Amendment and in effect as of the Closing Date, the “LC Agreement”), by and among Tenet, the LC participants and issuers party thereto and Barclays Bank PLC, as administrative agent (the “LC Agent”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-23-231607","anchor_url":"https://secwatch.observer/filing/0001193125-23-231607#claim-11c2c0efe699b4a4f26898531a4247bb3de38251","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/70318/000119312523231607/0001193125-23-231607-index.htm"},{"fact_type":"executive_change","fact_key":"9ba888cdc1","cik":70318,"ticker":"THC","company_name":"TENET HEALTHCARE CORP","filed_at":"2023-08-11T23:59:59+00:00","payload":{"action":"announced his retirement","action_category":"departure","departure_tone":"retirement","effective_date":"2023-12-31","interim":false,"role":"Executive Vice President & Chief Financial Officer","role_category":"cfo","successor_name":null,"successor_named":false},"claim":"Daniel Cancelmi departed as Executive Vice President & Chief Financial Officer at TENET HEALTHCARE CORP.","evidence_excerpt":"On January 19, 2023 , the Company filed the Report to disclose that Daniel Cancelmi, Executive Vice President & Chief Financial Officer, had announced his retirement from the Company, effective December 31, 2023.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000070318-23-000047","anchor_url":"https://secwatch.observer/filing/0000070318-23-000047#claim-9ba888cdc1","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/70318/000007031823000047/0000070318-23-000047-index.htm"},{"fact_type":"executive_change","fact_key":"4cf8412c23","cik":70318,"ticker":"THC","company_name":"TENET HEALTHCARE CORP","filed_at":"2023-08-10T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2023-08-09","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Roy Blunt was appointed as Director at TENET HEALTHCARE CORP.","evidence_excerpt":"On August 9, 2023 , the Board of Directors (the “Board”) of Tenet Healthcare Corporation (the “Company”) appointed Senator Roy Blunt to the Board, effective immediately.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000070318-23-000045","anchor_url":"https://secwatch.observer/filing/0000070318-23-000045#claim-4cf8412c23","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/70318/000007031823000045/0000070318-23-000045-index.htm"},{"fact_type":"earnings_release","fact_key":"8c9ae736307ff3eaa4ff11ffab5f7fd6b624b914","cik":70318,"ticker":"THC","company_name":"TENET HEALTHCARE CORP","filed_at":"2023-07-31T23:59:59+00:00","payload":{"eps_text":"$1.15","guidance_signal":"raised","item_codes_triggered":["2.02"],"net_income_text":"$123","period_text":"the quarter ended June 30, 2023","report_date":"2023-07-31","result_type":"reported_results","revenue_text":"$5,082"},"claim":"TENET HEALTHCARE CORP reported the quarter ended June 30, 2023 results: revenue $5,082, net income $123, EPS $1.15. Guidance raised.","evidence_excerpt":"Three Months Ended June 30, Six Months Ended June 30, ($ in millions, except per share results) 2023 2022 2023 2022 Net operating revenues $5,082 $4,638 $10,103 $9,383 Net income available to Tenet common shareholders from continuing operations $123 $38 $266 $177 Net income available to Tenet common shareholders from continuing operations per diluted share $1.15 $0.35 $2.47 $1.63 Adjusted EBITDA 1 excluding grant income $835 $749 $1,664 $1,631 Adjusted EBITDA 1 $843 $843 $1,675 $1,731 Adjusted diluted earnings per share from continuing operations 1 $1.44 $1.48 $2.87 $3.33","confidence":0.99,"filing_url":"https://secwatch.observer/filing/0000070318-23-000040","anchor_url":"https://secwatch.observer/filing/0000070318-23-000040#claim-8c9ae736307ff3eaa4ff11ffab5f7fd6b624b914","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/70318/000007031823000040/0000070318-23-000040-index.htm"},{"fact_type":"executive_change","fact_key":"3551a8b243","cik":70318,"ticker":"THC","company_name":"TENET HEALTHCARE CORP","filed_at":"2023-06-23T23:59:59+00:00","payload":{"action":"retirement","action_category":"departure","departure_tone":"retirement","effective_date":"2023-12-31","interim":false,"role":"Executive Vice President & Chief Financial Officer","role_category":"cfo","successor_name":"Sun Park","successor_named":true},"claim":"Daniel Cancelmi departed as Executive Vice President & Chief Financial Officer at TENET HEALTHCARE CORP.","evidence_excerpt":"Mr. Park will succeed Daniel Cancelmi, current Executive Vice President & Chief Financial Officer, whose previously announced retirement becomes effective on December 31, 2023.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000070318-23-000033","anchor_url":"https://secwatch.observer/filing/0000070318-23-000033#claim-3551a8b243","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/70318/000007031823000033/0000070318-23-000033-index.htm"},{"fact_type":"executive_change","fact_key":"a506a9c050","cik":70318,"ticker":"THC","company_name":"TENET HEALTHCARE CORP","filed_at":"2023-06-23T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-01-01","interim":false,"role":"Executive Vice President and Chief Financial Officer","role_category":"cfo","successor_name":null,"successor_named":false},"claim":"Sun Park was appointed as Executive Vice President and Chief Financial Officer at TENET HEALTHCARE CORP.","evidence_excerpt":"Sun Park, age 47, has been appointed Executive Vice President and Chief Financial Officer of the Company, effective January 1, 2024.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000070318-23-000033","anchor_url":"https://secwatch.observer/filing/0000070318-23-000033#claim-a506a9c050","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/70318/000007031823000033/0000070318-23-000033-index.htm"},{"fact_type":"executive_change","fact_key":"7172dc1e31","cik":70318,"ticker":"THC","company_name":"TENET HEALTHCARE CORP","filed_at":"2023-05-30T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2023-05-25","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Stephen H. Rusckowski was appointed as Director at TENET HEALTHCARE CORP.","evidence_excerpt":"On May 25, 2023 , the Board of Directors (the “Board”) of Tenet Healthcare Corporation (the “Company”) appointed Stephen H. Rusckowski to the Board, effective immediately.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000070318-23-000028","anchor_url":"https://secwatch.observer/filing/0000070318-23-000028#claim-7172dc1e31","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/70318/000007031823000028/0000070318-23-000028-index.htm"},{"fact_type":"shareholder_vote","fact_key":"5835eea2d98eee7e35469da7c96b07501c36a43e","cik":70318,"ticker":"THC","company_name":"TENET HEALTHCARE CORP","filed_at":"2023-05-25T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2023-05-25","outcome":"failed","proposal_text":"Shareholder proposal requesting a report on patients' right to access abortion in emergencies","proposal_type":"other","results":[{"broker_non_votes":"6,815,599","subject":null,"votes_abstain":"1,685,044","votes_against":"77,442,867","votes_for":"7,449,831","votes_withheld":null}]},"claim":"TENET HEALTHCARE CORP shareholders rejected Shareholder proposal requesting a report on patients' right to access abortion in emergencies at the 2023-05-25 meeting.","evidence_excerpt":"5. The shareholder proposal requesting a report on patients’ right to access abortion in emergencies did not pass","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0000070318-23-000026","anchor_url":"https://secwatch.observer/filing/0000070318-23-000026#claim-5835eea2d98eee7e35469da7c96b07501c36a43e","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/70318/000007031823000026/0000070318-23-000026-index.htm"},{"fact_type":"shareholder_vote","fact_key":"f94f6039a59aad7b6ae113747ecbff0391ed700f","cik":70318,"ticker":"THC","company_name":"TENET HEALTHCARE CORP","filed_at":"2023-05-25T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2023-05-25","outcome":"passed","proposal_text":"Ratification of selection of Deloitte & Touche LLP as independent auditor for 2023","proposal_type":"auditor_ratification","results":[{"broker_non_votes":"—","subject":null,"votes_abstain":"39,675","votes_against":"742,949","votes_for":"92,610,717","votes_withheld":null}]},"claim":"TENET HEALTHCARE CORP shareholders approved Ratification of selection of Deloitte & Touche LLP as independent auditor for 2023 at the 2023-05-25 meeting.","evidence_excerpt":"4. The Company’s shareholders approved the ratification of the selection of Deloitte & Touche LLP as the Company’s independent registered public accountants for the year ending December 31, 2023:","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0000070318-23-000026","anchor_url":"https://secwatch.observer/filing/0000070318-23-000026#claim-f94f6039a59aad7b6ae113747ecbff0391ed700f","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/70318/000007031823000026/0000070318-23-000026-index.htm"},{"fact_type":"shareholder_vote","fact_key":"cd4f65fc183c3cb23c72365960987226ca230813","cik":70318,"ticker":"THC","company_name":"TENET HEALTHCARE CORP","filed_at":"2023-05-25T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2023-05-25","outcome":"passed","proposal_text":"Advisory vote on frequency of future advisory votes on executive compensation","proposal_type":"say_on_pay_frequency","results":[{"broker_non_votes":"6,815,599","subject":null,"votes_abstain":"28,642","votes_against":null,"votes_for":"84,450,639","votes_withheld":null}]},"claim":"TENET HEALTHCARE CORP shareholders approved Advisory vote on frequency of future advisory votes on executive compensation at the 2023-05-25 meeting.","evidence_excerpt":"3. Votes regarding the approval, on an advisory basis, of the frequency of future advisory votes on the Company’s executive compensation were as follows: ONE YEAR TWO YEARS THREE YEARS ABSTAIN BROKER NON-VOTES 84,450,639 40,680 2,057,781 28,642 6,815,599","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0000070318-23-000026","anchor_url":"https://secwatch.observer/filing/0000070318-23-000026#claim-cd4f65fc183c3cb23c72365960987226ca230813","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/70318/000007031823000026/0000070318-23-000026-index.htm"},{"fact_type":"shareholder_vote","fact_key":"85113dc7a7733039bc96040d99e0f49ffa5ce335","cik":70318,"ticker":"THC","company_name":"TENET HEALTHCARE CORP","filed_at":"2023-05-25T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2023-05-25","outcome":"passed","proposal_text":"Advisory approval of the Company's executive compensation","proposal_type":"say_on_pay","results":[{"broker_non_votes":"6,815,599","subject":null,"votes_abstain":"429,727","votes_against":"4,617,910","votes_for":"81,530,105","votes_withheld":null}]},"claim":"TENET HEALTHCARE CORP shareholders approved Advisory approval of the Company's executive compensation at the 2023-05-25 meeting.","evidence_excerpt":"2. The Company’s shareholders approved, on an advisory basis, the Company’s executive compensation:","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0000070318-23-000026","anchor_url":"https://secwatch.observer/filing/0000070318-23-000026#claim-85113dc7a7733039bc96040d99e0f49ffa5ce335","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/70318/000007031823000026/0000070318-23-000026-index.htm"},{"fact_type":"shareholder_vote","fact_key":"d287892d4c2f1969b51791b3e07cf121bcec197a","cik":70318,"ticker":"THC","company_name":"TENET HEALTHCARE CORP","filed_at":"2023-05-25T23:59:59+00:00","payload":{"item_codes_triggered":["5.07"],"meeting_date":"2023-05-25","outcome":"passed","proposal_text":"Election of Directors","proposal_type":"director_election","results":[{"broker_non_votes":"6,815,599","subject":"J. Robert Kerrey","votes_abstain":"514,682","votes_against":"2,527,226","votes_for":"83,535,834","votes_withheld":null},{"broker_non_votes":"6,815,599","subject":"James L. Bierman","votes_abstain":"508,827","votes_against":"922,183","votes_for":"85,146,732","votes_withheld":null},{"broker_non_votes":"6,815,599","subject":"Richard W. Fisher","votes_abstain":"507,356","votes_against":"1,026,111","votes_for":"85,044,275","votes_withheld":null},{"broker_non_votes":"6,815,599","subject":"Meghan M. FitzGerald","votes_abstain":"506,663","votes_against":"1,243,901","votes_for":"84,827,178","votes_withheld":null},{"broker_non_votes":"6,815,599","subject":"Cecil D. Haney","votes_abstain":"507,121","votes_against":"933,335","votes_for":"85,137,286","votes_withheld":null},{"broker_non_votes":"6,815,599","subject":"Christopher S. Lynch","votes_abstain":"508,275","votes_against":"986,640","votes_for":"85,082,827","votes_withheld":null},{"broker_non_votes":"6,815,599","subject":"Richard J. Mark","votes_abstain":"507,240","votes_against":"987,427","votes_for":"85,083,075","votes_withheld":null},{"broker_non_votes":"6,815,599","subject":"Tammy Romo","votes_abstain":"507,506","votes_against":"1,161,247","votes_for":"84,908,989","votes_withheld":null},{"broker_non_votes":"6,815,599","subject":"Saumya Sutaria","votes_abstain":"511,541","votes_against":"401,556","votes_for":"85,664,645","votes_withheld":null},{"broker_non_votes":"6,815,599","subject":"Nadja Y. West","votes_abstain":"508,482","votes_against":"929,376","votes_for":"85,139,884","votes_withheld":null}]},"claim":"TENET HEALTHCARE CORP shareholders approved Election of Directors at the 2023-05-25 meeting.","evidence_excerpt":"1. The Company’s shareholders elected the following directors to serve on the Company’s Board of Directors, each to serve until the next annual meeting of shareholders or until his or her successor is duly elected or qualified, whichever is later, or until the director’s earlier resignation or removal:","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0000070318-23-000026","anchor_url":"https://secwatch.observer/filing/0000070318-23-000026#claim-d287892d4c2f1969b51791b3e07cf121bcec197a","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/70318/000007031823000026/0000070318-23-000026-index.htm"},{"fact_type":"debt_financing","fact_key":"094c1cc76c1c7b76f9bf059665cf8f505f673200","cik":70318,"ticker":"THC","company_name":"TENET HEALTHCARE CORP","filed_at":"2023-05-16T23:59:59+00:00","payload":{"counterparty":"The Bank of New York Mellon Trust Company, N.A. (as trustee)","effective_date":"2023-05-16","event":"incurrence","instrument_type":"senior_notes","interest_rate_text":"6.750%","item_codes_triggered":["2.03"],"maturity_text":"2031","principal_text":"$1,350,000,000"},"claim":"TENET HEALTHCARE CORP incurred senior notes of $1,350,000,000 with The Bank of New York Mellon Trust Company, N.A. (as trustee) at 6.750% maturing 2031.","evidence_excerpt":"On May 16, 2023, Tenet Healthcare Corporation (“Tenet”) issued $1,350,000,000 in aggregate principal amount of 6.750% senior secured first lien notes due 2031 (the “Notes”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001193125-23-146125","anchor_url":"https://secwatch.observer/filing/0001193125-23-146125#claim-094c1cc76c1c7b76f9bf059665cf8f505f673200","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/70318/000119312523146125/0001193125-23-146125-index.htm"},{"fact_type":"earnings_release","fact_key":"8f93c2881934051c1d2f5d2a7b74301df95ed9c8","cik":70318,"ticker":"THC","company_name":"TENET HEALTHCARE CORP","filed_at":"2023-04-25T23:59:59+00:00","payload":{"eps_text":"$1.32 per diluted share","guidance_signal":"raised","item_codes_triggered":["2.02"],"net_income_text":"$143 million","period_text":"the quarter ended March 31, 2023","report_date":"2023-04-25","result_type":"reported_results","revenue_text":"$5,021"},"claim":"TENET HEALTHCARE CORP reported the quarter ended March 31, 2023 results: revenue $5,021, net income $143 million, EPS $1.32 per diluted share. Guidance raised.","evidence_excerpt":"results for first quarter 2023 versus first quarter 2022 are as follows: Three Months Ended March 31, ($ in millions, except per share results) 2023 2022 Net operating revenues $5,021 $4,745 Net income available to Tenet common shareholders from continuing operations $143 $139 Net income available to Tenet common shareholders from continuing operations per","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0000070318-23-000015","anchor_url":"https://secwatch.observer/filing/0000070318-23-000015#claim-8f93c2881934051c1d2f5d2a7b74301df95ed9c8","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/70318/000007031823000015/0000070318-23-000015-index.htm"},{"fact_type":"earnings_release","fact_key":"4023ce421cef50437a75fab555ca1143edfdecb4","cik":70318,"ticker":"THC","company_name":"TENET HEALTHCARE CORP","filed_at":"2023-02-09T23:59:59+00:00","payload":{"eps_text":"$0.92 per diluted share","guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":"$102 million","period_text":"quarter ended December 31, 2022","report_date":"2023-02-09","result_type":"reported_results","revenue_text":"$4,990"},"claim":"TENET HEALTHCARE CORP reported quarter ended December 31, 2022 results: revenue $4,990, net income $102 million, EPS $0.92 per diluted share.","evidence_excerpt":"2021 are as follows: Three Months Ended December 31, Twelve Months Ended December 31, ($ in millions, except per share results) 2022 2021 2022 2021 Net operating revenues $4,990 $4,856 $19,174 $19,485 Net income available to Tenet common shareholders from continuing operations $102 $250 $410 $915 Net income available to Tenet common shareholders from","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0000070318-23-000006","anchor_url":"https://secwatch.observer/filing/0000070318-23-000006#claim-4023ce421cef50437a75fab555ca1143edfdecb4","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/70318/000007031823000006/0000070318-23-000006-index.htm"},{"fact_type":"earnings_release","fact_key":"a0c377ddf7609bdd33d2460fe26964d677bc0b34","cik":70318,"ticker":"THC","company_name":"TENET HEALTHCARE CORP","filed_at":"2023-01-19T23:59:59+00:00","payload":{"eps_text":null,"guidance_signal":"raised","item_codes_triggered":["2.02"],"net_income_text":null,"period_text":"the fiscal year ended December 31, 2022","report_date":"2023-01-19","result_type":"guidance_update","revenue_text":null},"claim":"TENET HEALTHCARE CORP updated its the fiscal year ended December 31, 2022 guidance (raised).","evidence_excerpt":"On January 19, 2023, Tenet Healthcare Corporation (the “Company”) issued a press release announcing the Company’s expectation that its Adjusted EBITDA, excluding any fourth quarter stimulus grant income related to the pandemic, will beat the midpoint of the Adjusted EBITDA Outlook range for the fiscal year ended December 31, 2022 that was previously disclosed in the Company’s press release dated October 20, 2022 reporting third quarter 2022 results.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0000070318-23-000004","anchor_url":"https://secwatch.observer/filing/0000070318-23-000004#claim-a0c377ddf7609bdd33d2460fe26964d677bc0b34","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/70318/000007031823000004/0000070318-23-000004-index.htm"},{"fact_type":"executive_change","fact_key":"65e60578f9","cik":70318,"ticker":"THC","company_name":"TENET HEALTHCARE CORP","filed_at":"2023-01-19T23:59:59+00:00","payload":{"action":"announced retirement","action_category":"departure","departure_tone":"retirement","effective_date":"2023-12-31","interim":false,"role":"Chief Financial Officer","role_category":"cfo","successor_name":null,"successor_named":false},"claim":"Daniel Cancelmi departed as Chief Financial Officer at TENET HEALTHCARE CORP.","evidence_excerpt":"Daniel Cancelmi, Executive Vice President & Chief Financial Officer, has announced his retirement from the Company, effective December 31, 2023.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0000070318-23-000004","anchor_url":"https://secwatch.observer/filing/0000070318-23-000004#claim-65e60578f9","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/70318/000007031823000004/0000070318-23-000004-index.htm"},{"fact_type":"executive_change","fact_key":"0fa3961fd0","cik":70318,"ticker":"THC","company_name":"TENET HEALTHCARE CORP","filed_at":"2022-10-03T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2022-10-01","interim":false,"role":"Chairman of the Board","role_category":"chair","successor_name":null,"successor_named":false},"claim":"J. Robert Kerrey was appointed as Chairman of the Board at TENET HEALTHCARE CORP.","evidence_excerpt":"The Board appointed J. Robert Kerrey as Chairman of the Board effective as of October 1, 2022, and reduced the number of authorized directors on the Board to ten.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001193125-22-256098","anchor_url":"https://secwatch.observer/filing/0001193125-22-256098#claim-0fa3961fd0","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/70318/000119312522256098/0001193125-22-256098-index.htm"},{"fact_type":"executive_change","fact_key":"6b9c43137f","cik":70318,"ticker":"THC","company_name":"TENET HEALTHCARE CORP","filed_at":"2022-10-03T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2022-10-01","interim":false,"role":"Executive Chairman","role_category":"chair","successor_name":"J. Robert Kerrey","successor_named":true},"claim":"Ronald A. Rittenmeyer resigned as Executive Chairman at TENET HEALTHCARE CORP.","evidence_excerpt":"Ronald A. Rittenmeyer, who had served as the Executive Chairman of Tenet Healthcare Corporation (the “Company”) and as a member of the board of directors of the Company (the “Board”), resigned due to personal health reasons effective as of October 1, 2022.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001193125-22-256098","anchor_url":"https://secwatch.observer/filing/0001193125-22-256098#claim-6b9c43137f","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/70318/000119312522256098/0001193125-22-256098-index.htm"},{"fact_type":"executive_change","fact_key":"f7cf8a6a33","cik":70318,"ticker":"THC","company_name":"TENET HEALTHCARE CORP","filed_at":"2022-02-25T23:59:59+00:00","payload":{"action":"will serve as","action_category":"role_change","departure_tone":"not_applicable","effective_date":"2024-01-01","interim":false,"role":"senior advisor","role_category":"other_named_officer","successor_name":null,"successor_named":false},"claim":"Ronald A. Rittenmeyer changed role as senior advisor at TENET HEALTHCARE CORP.","evidence_excerpt":"the Amendment provides that, between January 1, 2024 and December 31, 2025 when Mr. Rittenmeyer will serve as a senior advisor to the Chief Executive Officer and the Company’s board of directors","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001193125-22-054689","anchor_url":"https://secwatch.observer/filing/0001193125-22-054689#claim-f7cf8a6a33","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/70318/000119312522054689/0001193125-22-054689-index.htm"},{"fact_type":"executive_change","fact_key":"88ae686566","cik":70318,"ticker":"THC","company_name":"TENET HEALTHCARE CORP","filed_at":"2021-09-03T23:59:59+00:00","payload":{"action":"promoted","action_category":"role_change","departure_tone":"not_applicable","effective_date":"2021-09-01","interim":false,"role":"Chief Executive Officer","role_category":"ceo","successor_name":null,"successor_named":false},"claim":"Saumya Sutaria, M.D. changed role as Chief Executive Officer at TENET HEALTHCARE CORP.","evidence_excerpt":"Saumya Sutaria, M.D., will be promoted from President and Chief Operating Officer of the Company to Chief Executive Officer of the Company, in each case effective as of September 1, 2021","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001193125-21-265516","anchor_url":"https://secwatch.observer/filing/0001193125-21-265516#claim-88ae686566","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/70318/000119312521265516/0001193125-21-265516-index.htm"},{"fact_type":"executive_change","fact_key":"49561ba917","cik":70318,"ticker":"THC","company_name":"TENET HEALTHCARE CORP","filed_at":"2021-09-03T23:59:59+00:00","payload":{"action":"transitioned","action_category":"role_change","departure_tone":"not_applicable","effective_date":"2021-09-01","interim":false,"role":"Executive Chairman","role_category":"chair","successor_name":null,"successor_named":false},"claim":"Ronald A. Rittenmeyer changed role as Executive Chairman at TENET HEALTHCARE CORP.","evidence_excerpt":"Ronald A. Rittenmeyer will transition from Chief Executive Officer of the Company and continue as the Executive Chairman of the Company and the Company’s board of directors (the “ Board ”) through 2022","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001193125-21-265516","anchor_url":"https://secwatch.observer/filing/0001193125-21-265516#claim-49561ba917","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/70318/000119312521265516/0001193125-21-265516-index.htm"},{"fact_type":"executive_change","fact_key":"8ebd0ea532","cik":70318,"ticker":"THC","company_name":"TENET HEALTHCARE CORP","filed_at":"2021-08-10T23:59:59+00:00","payload":{"action":"promoted","action_category":"role_change","departure_tone":"not_applicable","effective_date":"2021-09-01","interim":false,"role":"Chief Executive Officer","role_category":"ceo","successor_name":null,"successor_named":false},"claim":"Saumya Sutaria changed role as Chief Executive Officer at TENET HEALTHCARE CORP.","evidence_excerpt":"Ronald A. Rittenmeyer will transition from Chief Executive Officer of the Company and continue as the Executive Chairman of the Company and the Board of Directors of the Company through 2022, and Saumya Sutaria, M.D., will be promoted from President and Chief Operating Officer of the Company to the Chief Executive Officer of the Company, in each case effective as of September 1, 2021.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001193125-21-241133","anchor_url":"https://secwatch.observer/filing/0001193125-21-241133#claim-8ebd0ea532","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/70318/000119312521241133/0001193125-21-241133-index.htm"},{"fact_type":"executive_change","fact_key":"dd21199147","cik":70318,"ticker":"THC","company_name":"TENET HEALTHCARE CORP","filed_at":"2021-08-10T23:59:59+00:00","payload":{"action":"transitioned","action_category":"role_change","departure_tone":"not_applicable","effective_date":"2021-09-01","interim":false,"role":"Executive Chairman","role_category":"chair","successor_name":"Saumya Sutaria","successor_named":true},"claim":"Ronald A. Rittenmeyer changed role as Executive Chairman at TENET HEALTHCARE CORP.","evidence_excerpt":"Ronald A. Rittenmeyer will transition from Chief Executive Officer of the Company and continue as the Executive Chairman of the Company and the Board of Directors of the Company through 2022, and Saumya Sutaria, M.D., will be promoted from President and Chief Operating Officer of the Company to the Chief Executive Officer of the Company, in each case effective as of September 1, 2021.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001193125-21-241133","anchor_url":"https://secwatch.observer/filing/0001193125-21-241133#claim-dd21199147","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/70318/000119312521241133/0001193125-21-241133-index.htm"}]}